您好,欢迎来到上海士研管理咨询有限公司
产业峰会 演讲局 专家智库服务 峰会活动服务 整合营销服务
  • 产业峰会:
    以专业团队对产业和市场客观详实地调研为前提,拥有战略性、系统性、全球性的基因,汇集了领导者关注的热点话题与领袖代表,为您提供“一站式”的对话、分享、社交平台!
  • 演讲局:
    致力于为全球企业和机构提供主题演讲家、高管大师班、董事会顾问,每项服务都提供了一种更深入、更具互动性的体验,尤其是针对较小的精选受众和关键个人。我们拥有最具影响力的商业领袖和顶级专家的资源,他们是各自领域的最杰出的代表。我们的团队由经验丰富的演讲和活动经理组成,我们注重建立长期而深入的伙伴关系。
  • 专家智库服务:
    中国领先的行业专家知识信息服务供应商,为需要专业洞见的商业决策者匹配具有一手经验的行业专家,助力他们以更加明确的目标和坚定的信心做出决策。我们有60万余名专家顾问遍布二十多个行业,而且每天还在增加!
  • 峰会活动服务:
    致力于成为全球最专业的产业峰会活动提供商,为企业和机构的产业性峰会活动提供一站式专业服务,包括调研策划、定制邀请、营销推广、运营组织、项目管理、直播与数字化会议等,每项服务都由经验丰富的专业团队匹配长期沉淀的产业资源予以卓越执行,我们注重建立长期而深入的伙伴关系。
  • 整合营销服务:
    致力于成为全球领先的2B营销服务机构,聚焦产业高端活动、内容、渠道的建设与沉淀,为客户提供一站式整合营销解决方案,助力企业线上线下获客与品牌筑造。我们深信专业团队匹配产业资源带来卓越执行,我们注重建立长期而深入的伙伴关系。
嘉宾信息
发布时间: 2018 - 11 - 14
点击次数: 0
所属职位: 运营合伙人
所属公司: 鼎丰生科资本
个人简介:
Ben joined Pivotal Bioventure Partners as an Operating Partner from April, 2017. Ben has overall 24+ years’ extensive experience of global pharmaceutical R&D and business development in addition to building small biotech and CRO.  Before joining us, Dr. Ben Ni was CEO of iPharma (H.K) Ltd  (and i-Bridge operating partner) and from 2010-2017, Ben was the Head of External Innovation & Partnering, Strategy and Business Development, responsible for Sanofi licensing, transaction & partnering, from Asia pacific region. Since 1994, Ben worked as member of senior management team  in several global healthcare/pharmaceutical companies such as Eli Lilly/US (Action Group Chair), Covance (General Manager, Greater China), GSK (Neurodegenerative Disease Center, Global head ) where Ben has the proven track record of transitioning compounds from drug discovery/research phase into clinical development in several therapeutic areas and  plays pivotal roles in global R&D, Clinical service management in China. His value-add lies in broad and diverse scientific and business management expertise/knowledge in multi sectors of global healthcare industry under multi-culture environment in US and Asia.Ben has 40 publications in top international journals including Science, PNAS, five book chapters and four granted US patents. Ben is also adjunct professor in several universities in US and Singapore. Ben has been invited speaker in 60 international conferences and professional seminars.Ben holds a Ph. D in molecular pharmacology from University of Toronto under fellowship and post-doctoral fellowship in Clinical Pharmacology from National Institute of Health.
发布时间: 2018 - 06 - 29
点击次数: 0
所属职位: 创始人兼CEO
所属公司: 奕安济世生物药业
个人简介:
赵奕宁博士是奕安济世生物药业 (Hangzhou Just Biotherapeutics) 的创始人及总裁。奕安济世生物药业是一家专注于致力于研发与生产国际质量标准生物药的创新公司。在创立自己的公司之前,赵奕宁博士在多家著名跨国制药公司从事近 20年的战略管理、商务开发、产品拓展及公司并购的相关业务。他曾在位于美国加州的安进公司 (AMGEN) 担任全球商业运作战略总监,期间负责美国和欧洲以外的30个国家的市场进入战略与生物类似药的商业化运作。在加入安进公司之前,赵博士在位于纽约的辉瑞制药公司 (Pfizer)负责亚洲战略,涵盖小分子、生物制药和疫苗等领域。赵奕宁博士目前还担任奕真生物科技(Veritas Genetics)和奕景生物科技 (NuBiyota) 的总裁,这高科技两家公司分别专注于基因类药物开发生产和肠道微生态治疗。赵奕宁博士是浙江省“千人计划”特聘专家。赵奕宁博士毕业于复旦大学药学院,拥有比利时根特大学(Ghent University)分析化学博士学位和麻省理工学院 (MIT) MBA学位。他发表过30多部专业文章。
发布时间: 2017 - 07 - 04
点击次数: 0
所属职位: 总监
所属公司: 汇桥资本LB医疗基金
个人简介:
Dr. Bin Li is the founder and CIO of ABG-LB Healthcare Fund and a partner of Ally Bridge Group, a global healthcare investment fund based in Hong Kong. Previously, he was a Managing Director and the Head of Greater China Healthcare Research at Morgan Stanley and led the coverage of Greater China healthcare industry. Since he moved to Morgan Stanley and established the healthcare research practice in Hong Kong in 2008, he had been ranked as the top analyst in China healthcare industry by the most widely recognized investor surveys. He was ranked No. 1 Asia Healthcare Analyst by the Institutional Investor (II) for seven consecutive years (2008-2014) and No.1 China Healthcare Analyst each year by II since the poll started in 2010 (2010-2014). He was also repeatedly ranked as No. 1 Asia Healthcare Analyst by all other independent investor surveys including Greenwich and Asiamoney. In addition, he was rated as No. 1 in Wall Street Journal's Best Asia Healthcare Analysts poll for his stock selection in 2010. Before joining Morgan Stanley, he was a senior healthcare research analyst at Merrill Lynch (Hong Kong) and responsible for the firm’s stock research efforts on Asia healthcare. Before moving to Hong Kong in 2007, he was a key member of a top-rank US pharmaceutical research team at Merrill Lynch based in New York. Dr. Li has over 20-year experience in healthcare industry. He received his Ph.D. in biochemistry and MBA from New York University and bachelor degree from Fudan University, China. Prior to his sell-side career, he worked at Merck Research Laboratory as a scientist and published papers on peer-reviewed science journals.
发布时间: 2016 - 10 - 18
点击次数: 0
所属职位: 首席数据官
所属公司: 奥美广告
个人简介:
首席数据官
微信公众号
领导者网络APP
友情链接
Copyright ©2005 - 2017上海士研管理咨询有限公司
犀牛云提供企业云服务